drugset / Trial / NCT06451302

Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study

NCT06451302

Active not recruiting 100 enrolled Yizhuo Zhang
NaSingle-groupOpen-labelTreatment

Summary

The aim is to evaluate the outcome and safety of risk-stratification oriented treatment for pediatric Ewing sarcoma in multicenters .

Timeline

Start
2024-04-17
Primary completion
2027-05-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified
Subject Doxorubicin Other / unclassified
Subject Etoposide Small molecule
Subject Ifosfamide Small molecule
Subject Vincristine Small molecule

Indications